Literature DB >> 14872016

DWI abnormalities and clinical characteristics in TIA patients.

Y Inatomi1, K Kimura, T Yonehara, S Fujioka, M Uchino.   

Abstract

OBJECTIVE: To determine the clinical characteristics of diffusion-weighted images (DWIs) in patients with TIA.
METHODS: The authors performed prospectively MRI including DWI in 129 consecutively studied patients with TIA (mean age, 67 years; 68% men) within 14 days after TIA onset. They examined the frequency of TIA-related DWI abnormalities and compared the clinical background of patients with and without DWI abnormalities. Using multivariate statistical methods, the authors investigated the independent factors associated with detection of DWI abnormalities.
RESULTS: Fifty-seven patients with TIA (44%) had DWI abnormalities (positive group), whereas 72 (56%) had no abnormalities (negative group). Prolonged TIA duration (TIA duration > or = 30 minutes), hemiparesis, monoparesis, disturbance of higher brain function, history of either stroke or TIA, diabetes mellitus, and atrial fibrillation were observed more frequently in the positive group than in the negative group. No difference in other symptoms, vascular risk factors, or emboligenic cardiac and arterial disease was observed between the two groups. A multiple logistic regression model demonstrated that prolonged TIA duration (odds ratio [OR], 3.7; 95% CI, 1.3 to 10.8) and disturbance of higher brain function (OR, 10.2; 95% CI, 2.2 to 46.9) are significant and independent factors in correlating with DWI abnormalities.
CONCLUSIONS: TIA-related DWI abnormalities are associated with prolonged duration of TIA and disturbance of higher brain function. More sustained and extensive ischemia may contribute to DWI abnormalities in patients with TIA.

Entities:  

Mesh:

Year:  2004        PMID: 14872016     DOI: 10.1212/01.wnl.0000110303.57683.3a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Transient ischemic attack: are there different types or classes? Risk of stroke and treatment options.

Authors:  Hakan Ay; Walter J Koroshetz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Diffusion-weighted MR imaging in transient ischaemic attacks.

Authors:  C Lamy; C Oppenheim; D Calvet; V Domigo; O Naggara; J L Méder; J L Mas
Journal:  Eur Radiol       Date:  2006-01-05       Impact factor: 5.315

Review 3.  Evolving concepts regarding transient ischemic attacks.

Authors:  Bernardo Liberato; Shyam Prabhakaran; Ralph L Sacco
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

4.  The use of neurovascular imaging for triaging TIA and minor stroke: implications for therapy.

Authors:  Andrew M Demchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

5.  Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?

Authors:  C Oppenheim; C Lamy; E Touzé; D Calvet; M Hamon; J-L Mas; J-F Méder
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

6.  Cerebral ultrasound perfusion imaging in a migraine attack with prolonged aura.

Authors:  Wael Marouf; Andreas Hetzel; Matthias Reinhard; Wolf-Dirk Niesen
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

7.  Multimodal imaging in acute ischemic stroke.

Authors:  William A Copen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 8.  Transient ischemic attack: definition and natural history.

Authors:  Louis R Caplan
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

9.  Frequency of emerging positive diffusion-weighted imaging in early repeat examinations at least 24 h after transient ischemic attacks.

Authors:  Naomi Morita; Masafumi Harada; Junichiro Satomi; Yuka Terasawa; Ryuji Kaji; Shinji Nagahiro
Journal:  Neuroradiology       Date:  2012-11-16       Impact factor: 2.804

10.  Yield of combined perfusion and diffusion MR imaging in hemispheric TIA.

Authors:  M Mlynash; J-M Olivot; D C Tong; M G Lansberg; I Eyngorn; S Kemp; M E Moseley; G W Albers
Journal:  Neurology       Date:  2008-12-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.